ERBB2 and breast carcinoma: When considering the current paradigm that PD-1/PD-L1 allows the immune evasion of aggressive tumors associated with poor prognosis, our findings that the PD-1 positive PAGES-HBC is a good prognostic indicator in HER2+ breast cancer are counterintuitive.